BRCA1/2 Genetic Testing Found Cost-Effective in Current Era
SABCS Conference Coverage
Can Medicare Sustain Widespread Access to GLP-1 Therapies?
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
AJMC® in the Press, April 25, 2025
Trump Tariffs on Pharmaceuticals Risk Causing Higher Costs, Drug Shortages